Why not run healthcare like a business?

Susan DeVote, president and CEO of Premier, says if you want to fix healthcare, you have to start from the inside. That means improving the delivery of healthcare by collaborating and sharing information on everything from medical supplies to the latest treatments, she told Forbes.

“Healthcare systems spend 20 to 30 percent of their costs on buying stuff,” DeVore said. “They buy drugs. They buy capital equipment. They buy medical devices. Overall, we have a $41 billion market opportunity to help healthcare systems buy together.”

Read more below:

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.